Comparison of multimodality treatment; 2 or 4 courses of Paclitaxel/CDDP or S1/CDDP followed by surgery for locally advanced gastric cancer, a randomized phase II trial (COMPASS)
Phase 2
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000002595
- Lead Sponsor
- COMPASS research group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe medical condition 2. Malignant tumors of other organs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival rate at three years
- Secondary Outcome Measures
Name Time Method